NEW YORK (GenomeWeb) – Syntekabio, a bioinformatics startup from South Korea, said today that it has closed a ₩12 billion ($11.2 million) Series B round of venture capital. Smilegate Investment led the round, with participation from the Korea Development Bank, Korea Fixed-Income Investment Advisory, The Yozma Group Korea, and previous investor Altos Ventures.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.